| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.9M | +14.0% | -0.6% |
| Cost of Revenue | $8.3M | +41.8% | -0.6% |
| R&D Expense | $4.5M | -25.5% | +49.0% |
| SG&A Expense | $2.9M | +11.6% | +12.9% |
| Operating Income | $2.1M | +81.8% | -46.6% |
| Pre-tax Income | $2.2M | +238.7% | -41.7% |
| Income Tax | -$116K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.6M | -23.7% | -50.2% |
| Accounts Receivable | $14.4M | +52.8% | +557.2% |
| Inventory | $21.3M | +0.6% | +23.6% |
| Current Assets | $66.5M | +1.6% | +39.0% |
| Total Assets | $82.3M | +4.8% | +33.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.0M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | -$1.3M | — | — |
| Financing Cash Flow | $9.2M | — | — |
| Free Cash Flow | -$15.3M | — | — |
| -123.3% |
| -119.1% |
| Net Income | $2.4M | +1336.0% | -27.2% |
| EPS (Basic) | $0.03 | — | -25.0% |
| EPS (Diluted) | $0.03 | — | +0.0% |
| $21.9M |
| -8.9% |
| -9.4% |
| Total Liabilities | $29.4M | +2.7% | +0.8% |
| Stockholders' Equity | $52.9M | +6.0% | +63.1% |